Telbivudine
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 75 (Table of Contents)
Published: 6 Sep-2006
DOI: 10.3833/pdr.v2006.i75.467 ISSN: 1756-7874
Section: Deal Trackers
Fulltext:
Abstract
Telbivudine (originally LdT, short for β-2’-deoxy-L-thymidine) is under joint development by Idenix Pharmaceuticals (formerly Novirio Pharmaceuticals) and Novartis Pharma to treat chronic HBV infection...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS